scholarly journals In Vitro Evaluation of a Hypobromous Acid Hygiene Stabilized Solution in the Reduction of Bacterial Load Associated to Blepharitis Conditions

2021 ◽  
Author(s):  
Ludovica Silvani ◽  
Andrea Campus Bedei ◽  
Laura Castellini ◽  
Giulia De grazia ◽  
Stefano Remiddi
Keyword(s):  
Bacterial Species ◽  
Bacterial Load ◽  
Clinical Manifestations ◽  
Daily Practice ◽  
Skin Area ◽  
Treatment And Prevention ◽  
Promising Tool ◽  
Bromine Solution ◽  
Active Bromine

Abstract Blepharitis is a chronic inflammation of the periocular skin area and it is characterized by eye itching, burning, dryness and irritation, with progression to chronic dry eye syndrome, where the eyelids margins of blepharitis patients are frequently colonized by bacteria.The aim of the present study was to investigate the in vitro bactericidal activity (BA) of a stabilized active bromine solution (MDI-102) at neutral pH for the potential use in the treatment and prevention of blepharitis.The time kill assays have been conducted both in clean and in dirty conditions (by using bovine albumin solution as the interfering substance) at different ranges of concentration.The results show the topical solution to be capable of inactivating, in less than 0.5 minutes, more than 99.9% of several bacterial species involved in the clinical manifestations of blepharitis: Enterococcus hirae, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, Serratia marcescens. Dirty condition tests confirm the results shown without albumin (clean conditions).This study demonstrates that MDI-102 active bromine solution can markedly reduce (in vitro) the bacterial activity, responsible of clinical manifestation of blepharitis. Thus, MDI-102 can be considered a promising tool for the periocular area and eyelids cleaning for blepharitis patients.The use of this formulation may contribute in the long-term prevention and hygienic treatment of blepharitis condition. Furthermore, MDI-102 can be considered as an alternative to reduce the use and the abuse of topical antibiotics in the daily practice, which may contribute to the increase of resistance to the antibiotics in the clinical setting.

scholarly journals Volatile scents of influenza A and S. pyogenes (co-)infected cells

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Selina Traxler ◽  
Gina Barkowsky ◽  
Radost Saß ◽  
Ann-Christin Klemenz ◽  
Nadja Patenge ◽  
...  
Keyword(s):  
Influenza A ◽  
Early Recognition ◽  
Bacterial Species ◽  
Bacterial Load ◽  
Gas Chromatography Mass Spectrometry ◽  
Sampling System ◽  
Infected Cells ◽  
Infection Processes ◽  
Non Destructive

AbstractInfluenza A is a serious pathogen itself, but often leads to dangerous co-infections in combination with bacterial species such as Streptococcus pyogenes. In comparison to classical biochemical methods, analysis of volatile organic compounds (VOCs) in headspace above cultures can enable destruction free monitoring of metabolic processes in vitro. Thus, volatile biomarkers emitted from biological cell cultures and pathogens could serve for monitoring of infection processes in vitro. In this study we analysed VOCs from headspace above (co)-infected human cells by using a customized sampling system. For investigating the influenza A mono-infection and the viral-bacterial co-infection in vitro, we analysed VOCs from Detroit cells inoculated with influenza A virus and S. pyogenes by means of needle-trap micro-extraction (NTME) and gas chromatography mass spectrometry (GC-MS). Besides the determination of microbiological data such as cell count, cytokines, virus load and bacterial load, emissions from cell medium, uninfected cells and bacteria mono-infected cells were analysed. Significant differences in emitted VOC concentrations were identified between non-infected and infected cells. After inoculation with S. pyogenes, bacterial infection was mirrored by increased emissions of acetaldehyde and propanal. N-propyl acetate was linked to viral infection. Non-destructive monitoring of infections by means of VOC analysis may open a new window for infection research and clinical applications. VOC analysis could enable early recognition of pathogen presence and in-depth understanding of their etiopathology.

Probiotic properties of native Lactobacillus spp. strains for dairy calves

2018 ◽  
Vol 9 (4) ◽  
pp. 613-624 ◽  
Author(s):  
S. Fernández ◽  
M. Fraga ◽  
E. Silveyra ◽  
A.N. Trombert ◽  
A. Rabaza ◽  
...  
Keyword(s):  
Lactobacillus Reuteri ◽  
Bacterial Species ◽  
Control Group ◽  
Probiotic Properties ◽  
Real Time Quantitative Pcr ◽  
Treatment And Prevention ◽  
Probiotic Strains ◽  
Lactobacillus Spp

The use of native microorganisms with probiotic capacity is an alternative tool for the treatment and prevention of several diseases that affect animals, such as neonatal calf diarrhoea. The selection of probiotic strains within a collection is based on different in vitro and in vivo assays, which predict their potential. The aim of this study was to characterise a group of native Lactobacillus spp. strains isolated from faeces of healthy calves using an in vitro approach and to assess their ability to colonise the gastrointestinal tract (GIT) of calves. Native Lactobacillus spp. strains were evaluated on their capacity to survive low pH conditions and bile salts presence, biofilm formation and adhesion to both mucus and Caco-2 cells. Based on the in vitro characterisation, four strains (Lactobacillus johnsonii TP1.1, Lactobacillus reuteri TP1.3B, L. johnsonii TP1.6 and Lactobacillus amylovorus TP8.7) were selected to evaluate their capacity to colonise and persist in the GIT of calves. The assessment of enteric persistence involved an in vivo assay with oral administration of probiotics and quantification in faeces of the administered bacterial species with real-time quantitative PCR (qPCR). The study was conducted using 15 calves (1-month-old) which were divided into five groups of three animals, four of which were treated with four different selected strains and one was the control group. Strains TP1.3B and TP1.6 managed to persist in treated animals until ten days after the end of the administration period, indicating that they could be promising candidates for the design of probiotics for calves.

scholarly journals Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory Specimens

2015 ◽  
Vol 54 (3) ◽  
pp. 613-619 ◽  
Author(s):  
Mona A. Mahboubi ◽  
Lisa A. Carmody ◽  
Bridget K. Foster ◽  
Linda M. Kalikin ◽  
Donald R. VanDevanter ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Sequence Analysis ◽  
Dna Sequence ◽  
Bacterial Species ◽  
Bacterial Load ◽  
Considerable Proportion ◽  
Content Type ◽  
Culture Independent ◽  
Respiratory Specimens

Cystic fibrosis (CF) is characterized by chronic infection and inflammation of the airways.In vitroculture of select bacterial species from respiratory specimens has been used to guide antimicrobial therapy in CF for the past few decades. More recently, DNA sequence-based, culture-independent approaches have been used to assess CF airway microbiology, although the role that these methods will (or should) have in routine microbiologic analysis of CF respiratory specimens is unclear. We performed DNA sequence analyses to detect bacterial species in 945 CF sputum samples that had been previously analyzed by selective CF culture. We determined the concordance of results based on culture and sequence analysis, highlighting the comparison of the results for the most prevalent genera. Although overall prevalence rates were comparable between the two methods, results varied by genus. While sequence analysis was more likely to detectAchromobacter,Stenotrophomonas, andBurkholderia, it was less likely to detectStaphylococcus.Streptococcusspp. were rarely reported in culture results but were the most frequently detected species by sequence analysis. A variety of obligate and facultative anaerobic species, not reported by culture, was also detected with high prevalence by sequence analysis. Sequence analysis indicated that in a considerable proportion of samples, taxa not reported by selective culture constituted a relatively high proportion of the total bacterial load, suggesting that routine CF culture may underrepresent significant segments of the bacterial communities inhabiting CF airways.

scholarly journals Candida albicans as an Essential “Keystone” Component within Polymicrobial Oral Biofilm Models?

2020 ◽  
Vol 9 (1) ◽  
pp. 59
Author(s):  
Tracy Young ◽  
Om-Alkhir Alshanta ◽  
Ryan Kean ◽  
David Bradshaw ◽  
Jonathan Pratten ◽  
...  
Keyword(s):  
Candida Albicans ◽  
Bacterial Species ◽  
Bacterial Load ◽  
Oral Biofilm ◽  
Oral Biofilms ◽  
Health Products ◽  
Compositional Changes ◽  
Oral Therapeutic ◽  
Resazurin Dye

Background: Existing standardized biofilm assays focus on simple mono-species or bacterial-only models. Incorporating Candida albicans into complex biofilm models can offer a more appropriate and relevant polymicrobial biofilm for the development of oral health products. Aims: This study aimed to assess the importance of interkingdom interactions in polymicrobial oral biofilm systems with or without C. albicans, and test how these models respond to oral therapeutic challenges in vitro. Materials and Methods: Polymicrobial biofilms (two models containing 5 and 10 bacterial species, respectively) were created in parallel in the presence and absence of C. albicans and challenged using clinically relevant antimicrobials. The metabolic profiles and biomasses of these complex biofilms were estimated using resazurin dye and crystal violet stain, respectively. Quantitative PCR was utilized to assess compositional changes in microbial load. Additional assays, for measurements of pH and lactate, were included to monitor fluctuations in virulence “biomarkers.” Results: An increased level of metabolic activity and biomass in the presence of C. albicans was observed. Bacterial load was increased by more than a factor of 10 in the presence of C. albicans. Assays showed inclusion of C. albicans impacted the biofilm virulence profiles. C. albicans did not affect the biofilms’ responses to the short-term incubations with different treatments. Conclusions: The interkingdom biofilms described herein are structurally robust and exhibit all the hallmarks of a reproducible model. To our knowledge, these data are the first to test the hypothesis that yeasts may act as potential “keystone” components of oral biofilms.

scholarly journals Use of Quantum Dot Luminescent Probes To Achieve Single-Cell Resolution of Human Oral Bacteria in Biofilms

2006 ◽  
Vol 73 (2) ◽  
pp. 630-636 ◽  
Author(s):  
Natalia I. Chalmers ◽  
Robert J. Palmer ◽  
Laurence Du-Thumm ◽  
Richard Sullivan ◽  
Wenyuan Shi ◽  
...  
Keyword(s):  
Single Cell ◽  
Bacterial Species ◽  
Semiconductor Nanocrystals ◽  
Spatial Relationship ◽  
Oral Bacteria ◽  
Bacterial Cells ◽  
Interspecies Interactions ◽  
Promising Tool

ABSTRACT Oral biofilms are multispecies communities, and in their nascent stages of development, numerous bacterial species engage in interspecies interactions. Better insight into the spatial relationship between different species and how species diversity increases over time can guide our understanding of the role of interspecies interactions in the development of the biofilms. Quantum dots (QD) are semiconductor nanocrystals and have emerged as a promising tool for labeling and detection of bacteria. We sought to apply QD-based primary immunofluorescence for labeling of bacterial cells with in vitro and in vivo biofilms and to compare this approach with the fluorophore-based primary immunofluorescence approach we have used previously. To investigate QD-based primary immunofluorescence as the means to detect distinct targets with single-cell resolution, we conjugated polyclonal and monoclonal antibodies to the QD surface. We also conducted simultaneous QD conjugate-based and fluorophore conjugate-based immunofluorescence and showed that these conjugates were complementary tools in immunofluorescence applications. Planktonic and biofilm cells were labeled effectively by considering two factors: the final nanomolar concentration of QD conjugate and the amount of antibody conjugated to the QD, which we define as the degree of labeling. These advances in the application of QD-based immunofluorescence for the study of biofilms in vitro and in vivo will help to define bacterial community architecture and to facilitate investigations of interactions between bacterial species in these communities.

scholarly journals MECHANISMS OF DEVELOPMENT, OPPORTUNITIES FOR DIAGNOSTICS, TREATMENT, AND PREVENTION OF ALLERGIC RESPONSES TO DRUGS

2019 ◽  
Vol 22 (1) ◽  
pp. 42-50
Author(s):  
V. A. Bulgakova ◽  
T. I. Eliseeva ◽  
I. I. Balabolkin ◽  
I. E. Smirnov
Keyword(s):  
Drug Allergy ◽  
Pathological Condition ◽  
Clinical Manifestations ◽  
Underlying Disease ◽  
Cross Reactivity ◽  
Drug Of Choice ◽  
Treatment And Prevention ◽  
Wide Range

Drug allergy includes a wide range of immunological hypersensibility responses with various pathogenesis mechanisms and clinical manifestations. This is a serious type of adverse responses to drugs, which not only affects the quality of life of patients, complicates the treatment of the underlying disease, but in some cases is a potentially life-threatening pathological condition. Given the polymorphic symptoms of drug allergy, its diagnosis is often very difficult. The diagnosis is based on a thorough clinical examination of patients, in some cases, a special allergological examination may be required using in vitro and in vivo tests. An effective strategy for treating drug allergy is to prevent or block the action of a causally important drug. In the presence of alternative preparations, drugs that may cause allergies in a particular patient should be replaced with drugs with a fundamentally different chemical structure. When choosing alternative medications, possible cross-reactivity that occurs among drugs should be considered. Additional therapy in the management of patients with drug hypersensibility responses may include systemic and local corticosteroids, systemic antihistamines. In the case of anaphylaxis, the starting drug of choice is adrenaline. If in the presence of drug allergy to a certain preparation, it is not possible to find an adequate alternative and it is not possible to cancel this type of treatment, then the possibility of carrying out specific immunotherapy with this drug to induce tolerance to a causative drug may be considered.

Production of Novel Bioactive Compounds by the Bacteria Associated with Some Marine Sponges of Gulf of Mannar and Palk Bay, Southeast Coast of India

2018 ◽  
Vol 6 (8) ◽  
pp. 183
Author(s):  
V. Ramadas ◽  
G. Chandralega
Keyword(s):  
Bioactive Compounds ◽  
Bacterial Species ◽  
Marine Sponges ◽  
Marine Organisms ◽  
Gulf Of Mannar ◽  
Bacterial Symbionts ◽  
Palk Bay ◽  
Excellent Source

Sponges, exclusively are aquatic and mostly marine, are found from the deepest oceans to the edge of the sea. There are approximately 15,000 species of sponges in the world, of which, 150 occur in freshwater, but only about 17 are of commercial value. A total of 486 species of sponges have been identified in India. In the Gulf of Mannar and Palk Bay a maximum of 319 species of sponges have been recorded. It has been proved that marine organisms are excellent source of bioactive secondary metabolites and number of compounds of originated from marine organisms had been reported to possess in-vitro and in-vivo immuno stimulatory activity. Extracts from 20 sponge species were tested for bacterial symbionts and bioactive compounds were isolated from such associated bacterial species in the present study.

Nanoparticles and Its Implications in HIV/AIDS Therapy

2020 ◽  
Vol 17 (4) ◽  
pp. 448-456 ◽  
Author(s):  
Victor B. Oti
Keyword(s):  
Direct Injection ◽  
Oral Intake ◽  
Public Health Problem ◽  
Antiretroviral Drugs ◽  
The Body ◽  
Viral Agent ◽  
Treatment And Prevention ◽  
Prevention And Treatment ◽  
Hiv Aids

The use of Antiretroviral drugs in treating HIV/ AIDS patients has enormously increased their life spans with serious disadvantages. The virus infection still remains a public health problem worldwide with no cure and vaccine for the viral agent until now. The use of nanoparticles (NPs) for the treatment and prevention of HIV/AIDS is an emerging technology of the 21st century. NPs are solid and colloid particles with 10 nm to <1000 nm size range; although, less than 200 nm is the recommended size for nanomedical usage. There are NPs with therapeutic capabilities such as liposomes, micelles, dendrimers and nanocapsules. The particle enters the body mainly via oral intake, direct injection and inhalation. It has been proven to have potentials of advancing the prevention and treatment of the viral agent. Certain NPs have been shown to have selftherapeutic activity for the virus in vitro. Strategies that are novel are emerging which can be used to improve nanotechnology, such as genetic treatment and immunotherapy. In this review, nanoparticles, the types and its characteristics in drug delivery were discussed. The light was furthermore shed on its implications in the prevention and treatment of HIV/AIDS.

Sign in / Sign up

Export Citation Format

Share Document